Arginase: Structure, mechanism, and physiological role in male and female sexual arousal

Accounts of Chemical Research

Volumn 38, Issue 3, 2005, Pages 191-201

  Christianson, David W ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Dept of Chem and Chemical Biology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGININE; BORONIC ACID DERIVATIVE; HYDROXIDE; ISOENZYME; MANGANESE; NITRIC OXIDE SYNTHASE; ORNITHINE; UREA;

ARTICLE; CATALYSIS; CELLULAR DISTRIBUTION; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG SPECIFICITY; DRUG STRUCTURE; FEMALE GENITAL SYSTEM; HUMAN; HYDROLYSIS; MALE GENITAL SYSTEM; SEXUAL AROUSAL; SEXUAL DYSFUNCTION; SMOOTH MUSCLE RELAXATION; TISSUE DISTRIBUTION;

ANIMALS; ARGINASE; FEMALE; HISTONE DEACETYLASES; HUMANS; ISOENZYMES; MALE; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PENILE ERECTION; PENIS; PROTEIN STRUCTURE, QUATERNARY; RATS; REPRODUCTIVE BEHAVIOR; SUBSTRATE SPECIFICITY;

EID: 15244353301     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar040183k     Document Type: Article

References (71)

1. Ash, D. E.; Cox, J. D.; Christianson, D. W. Arginase: A Binuclear Manganese Metalloenzyme. In Manganese and Its Role in Biological Processes; Sigel, A., Sigel, H., Eds.; Metal Ions in Biological Systems, Vol. 37; M. Dekker: New York, 1999; pp 407-428.
2. Wu, G.; Morris, S. M., Jr. Arginine Metabolism: Nitric Oxide and Beyond. Biochem. J. 1998, 336, 1-17.
3. Krebs, H. A.; Henseleit, K. Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe-Seyler's Z. Physiol. Chem. 1932, 210, 33-66.
4. Herzfeld, A.; Raper, S. M. The Heterogeneity of Arginases in Rat Tissues. Biochem. J. 1976, 153, 469-478.
5. Morris, S. M., Jr. Regulation of Enzymes of the Urea Cycle and Arginine Metabolism. Annu. Rev. Nutr. 2002, 22, 87-105.
6. Morris, S. M., Jr.; Bhamidipati, D.; Kepka-Lenhart, D. Human Type II Arginase: Sequence Analysis and Tissue-Specific Expression. Gene 1997, 193, 157-161.
7. Shi, O.; Morris, S. M., Jr.; Zoghbi, H.; Porter, C. W.; O'Brien, W. E. Generation of a Mouse Model for Arginase II Deficiency by Targeted Disruption of the Arginase II Gene. Mol. Cell. Biol. 2001, 21, 811-813.
8. Albina, J. E.; Mills, C. D.; Henry, W. L., Jr.; Caldwell, M. D. Temporal Expression of Different Pathways of L-Arginine Metabolism in Healing Wounds. J. Immunol. 1990, 144, 3877-3880.
9. Wang, W. W.; Jenkinson, C. P.; Griscavage, J. M.; Kern, R. M.; Arabolos, N. S.; Byrnes, R. E.; Cederbaum, S. D.; Ignarro, L. J. Co-Induction of Arginase and Nitric Oxide Synthase in Murine Macrophages Activated by Lipopolysaccharide. Biochem. Biophys. Res. Commun. 1995, 210, 1009-1016.
10. Modolell, M.; Corraliza, I. M.; Link, F.; Soler, G.; Eichmann, K. Reciprocal Regulation of the Nitric Oxide Synthase/Arginase Balance in Mouse Bone Marrow-Derived Macrophages by TH1 and TH2 Cytokines. Eur. J. Immunol. 1995, 25, 1101-1104.
11. Sonoki, T.; Nagasaki, A.; Gotoh, T.; Takiguchi, M.; Takeya, M.; Matsuzaki, H.; Mori, M. Coninduction of Nitric Oxide Synthase and Arginase I in Cultured Rat Peritoneal Macrophages and Rat Tissues In Vivo by Lipopolysaccharide. J. Biol. Chem. 1997, 272, 3689-3693.
12. Chakder, S.; Rattan, S. L-Arginine Deficiency Causes Suppression of Nonadrenergic Noncholinergic Nerve-Mediated Smooth Muscle Relaxation: Role of L-citrulline Recycling. J. Pharmacol. Exp. Ther. 1997, 282, 378-384.
13. Baggio, R.; Emig, F. A.; Christianson, D. W.; Ash, D. E.; Chakder, S.; Rattan, S. Biochemical and Functional Profile of a Newly Developed Potent and Isozyme-Selective Arginase Inhibitor. J. Pharm. Exp. Ther. 1999, 290, 1409-1416.
14. Cox, J. D.; Kim, N. N.; Traish, A. M.; Christianson, D. W. Arginase-Boronic Acid Complex Highlights a Physiological Role in Erectile Function. Nat. Struct. Biol. 1999, 6, 1043-1047.
15. Kim, N. N.; Cox, J. D.; Baggio, R. F.; Emig, F. A.; Mistry, S. K.; Harper, S. L.; Speicher, D. W.; Morris, S. M., Jr.; Ash, D. E.; Traish, A.; Christianson, D. W. Probing Erectile Function: S-(2-Boronoethyl)-L-Cysteine Binds to Arginase as a Transition State Analogue and Enhances Smooth Muscle Relaxation in Human Penile Corpus Cavernosum. Biochemistry 2001, 40, 2678-2688.
16. Cama, E.; Colleluori, D. M.; Emig, F. A.; Shin, H.; Kim, S. W.; Kim, N. N.; Traish, A. M.; Ash, D. E.; Christianson, D. W. Human Arginase II: Crystal Structure and Physiological Role in Male and Female Sexual Arousal. Biochemistry 2003, 42, 8445-8451.
17. Xu, L.; Milliard, B.; Carmody, R. J.; Tsabary, G.; Shin, H.; Christianson, D. W.; Chen, Y. H. Arginase and Autoimmune Inflammation in the Central Nervous System. Immunology 2003, 110, 141-148.
18. Burnett, A. L.; Lowenstein, C. J.; Bredt, D. S.; Chang, T. S. K.; Snyder, S. H. Nitric Oxide: A Physiologic Mediator of Penile Erection. Science 1992, 257, 401-403.
19. Burnett, A. L. Nitric Oxide in the Penis: Physiology and Pathology. J. Urol. 1997, 157, 320-324.
20. Burnett, A. L.; Calvin, D. C.; Silver, R. I., Peppas, D. S.; Docimo, S. G. Immunohistochemical Description of Nitric Oxide Synthase Isoforms in Human Clitoris. J. Urol. 1997, 158, 75-78.
21. Hoyle, C. H. V.; Stones, R. W.; Robson, T.; Whitley, K.; Burnstock, G. Innervation of Vasculature and Microvasculature of the Human Vagina by NOS and Neuropeptide-Containing Nerves. J. Anat. 1996, 188, 633-644.
22. Traish, A. M.; Kim, N.; Min, K.; Munarriz, R.; Goldstein, I. Role of Androgens in Female Genital Sexual Arousal: Receptor Expression, Structure, and Function. Fertil. Steril. 2002, 77, S11-S18.
23. Kanyo, Z. F.; Scolnick, L. R.; Ash, D. E.; Christianson, D. W. Structure of a Unique Binuclear Manganese Cluster in Arginase. Nature 1996, 383, 554-557.
24. Reczkowski, R. S.; Ash, D. E. EPR Evidence for Binuclear Mn(II) Centers in Rat Liver Arginase. J. Am. Chem. Soc. 1992, 114, 10992-10994.
25. Khangulov, S. V.; Pessiki, P. J.; Barynin, V. V.; Ash, D. E.; Dismukes, G. C. Determination of the Metal Ion Separation and Energies of the Three Lowest Electronic States of Dimanganese-(II,II) Complexes and Enzymes: Catalase and Liver Arginase. Biochemistry 1995, 34, 2015-2025.
26. Cavalli, R. C.; Burke, C. J.; Kawamoto, S.; Soprano, D. R.; Ash, D. E. Mutagenesis of Rat Liver Arginase Expressed in Escherichia coli: Role of Conserved Histidines. Biochemistry 1994, 33, 10652-10657.
27. Scolnick, L. R.; Kanyo, Z. F.; Cavalli, R. C.; Ash, D. E.; Christianson, D. W. Altering the Binuclear Manganese Cluster of Arginase Diminishes Thermostability and Catalytic Function. Biochemistry 1997, 36, 10558-10565.
28. Cama, E.; Emig, F. A.; Ash, D. E.; Christianson, D. W. Structural and Functional Importance of First-Shell Metal Ligands in the Binuclear Manganese Cluster of Arginase I. Biochemistry 2003, 42, 7748-7758.
29. Dismukes, G. C. Manganese Enzymes with Binuclear Active Sites. Chem. Rev. 1996, 96, 2909-2926.
30. Kuhn, N. J.; Talbot, J.; Ward, S. pH-Sensitive Control of Arginase by Mn(II) Ions at Submicromolar Concentrations. Arch. Biochem. Biophys. 1991, 286, 217-221.
31. Cama, E.; Pethe, S.; Boucher, J.-L.; Han, S.; Emig, F. A.; Ash, D. E.; Viola, R. E.; Mansuy, D.; Christianson, D. W. Inhibitor Coordination Interactions in the Binuclear Manganese Cluster of Arginase. Biochemistry 2004, 43, 8987-8999.
32. Shin, H.; Cama, E.; Christianson, D. W. Design of Amino Acid Aldehydes as Transition-State Analogue Inhibitors of Arginase. J. Am. Chem. Soc. 2004, 126, 10278-10284.
33. DiCostanzo, L.; Centeno, F.; Christianson, D. W. Unpublished results.
34. Bewley, M. C.; Jeffrey, P. D.; Patchett, M. L.; Kanyo, Z. F.; Baker, E. N. Crystal Structures of Bacillus caldovelox Arginase in Complex with Substrate and Inhibitors Reveal New Insights into Activation, Inhibition and Catalysis in the Arginase Superfamily. Structure 1999, 7, 435-448.
35. Christianson, D. W.; Lipscomb, W. N. Carboxypeptidase A. Acc. Chem. Res. 1989, 22, 62-69.
36. 2-Arginase by Borate Leads to the Design of a Transition State Analogue Inhibitor, 2(S)-Amino-6-Boronohexanoic Acid. J. Am. Chem. Soc. 1997, 119, 8107-8108.
37. Baggio, R.; Cox, J. D.; Harper, S. L.; Speicher, D. W.; Christianson, D. W. A New Chromophoric Assay for Arginase Activity. Anal. Biochem. 1999, 276, 251-253.
38. Colleluori, D. M.; Ash, D. E. Classical and Slow-Binding Inhibitors of Human Type II Arginase. Biochemistry 2001, 40, 9356-9362.
39. Pauling, L. Molecular Architecture and Biological Reactions. Chem. Eng. News 1946, 24, 1375-1377.
40. Cama, E.; Shin, H.; Christianson, D. W. Design of Amino Acid Sulfonamides as Transition-State Analogue Inhibitors of Arginase. J. Am. Chem. Soc. 2003, 125, 13052-13057.
41. Cox, J. D.; Cama, E.; Colleluori, D. M.; Pethe, S.; Boucher, J.-L.; Mansuy, D.; Ash, D. E.; Christianson, D. W. Mechanistic and Metabolic Inferences from the Binding of Substrate Analogues and Products to Arginase. Biochemistry 2001, 40, 2689-2701.
42. Reczkowski, R. S.; Ash, D. E. Rat Liver Arginase: Kinetic Mechanism, Alternate Substrates, and Inhibitors. Arch. Biochem. Biophys. 1994, 312, 31-37.
43. Carvajal, N.; Cederbaum, S. D. Kinetics of Inhibition of Rat Liver and Kidney Arginases by Proline and Branched-Chain Amino Acids. Biochim. Biophys. Acta 1986, 870, 181-184.
44. G-Hydroxyl-L-Arginine: Implications for the Regulation of Nitric Oxide Biosynthesis by Arginase. Biochem. Biophys. Res. Commun. 1994, 202, 174-180.
45. ω-Hydroxy-L-Arginine, an Intermediate in the L-Arginine to Nitric Oxide Pathway, is a Strong Inhibitor of Liver and Macrophage Arginase. Biochem. Biophys. Res. Commun. 1994, 203, 1614-1621.
46. ω-Hydroxyamino-α-amino Acids as a New Class of Very Strong Inhibitors of Arginases. J. Biol. Inorg. Chem. 1996, 1, 73-82.
47. ω-Hydroxy-nor-L-arginine: a High-Affinity Inhibitor of Arginase Well Adapted to Bind to its Manganese Cluster. J. Am. Chem. Soc. 1997, 119, 4086-4087.
48. Pethe, S.; Boucher, J.-L.; Mansuy, D. Interaction of Anions with Rat Liver Arginase: Specific Inhibitory Effects of Fluoride. J. Inorg. Biochem. 2002, 88, 397-402.
49. Tormanen, C. D. Substrate Inhibition of Rat Liver and Kidney Arginase with Fluoride. J. Inorg. Biochem. 2003, 93, 243-246.
50. Kouzarides, T. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 1999, 9, 40-48.
51. Marmorstein, R. Structure of Histone Deacetylases: Insights into Substrate Recognition and Catalysis. Structure 2001, 9, 1127-1133.
52. Leipe, D. D.; Landsman, D. Histone Deacetylases, Acetoin Utilization Proteins and Acetylpolyamine Amidohydrolases are Members of an Ancient Protein Superfamily. Nucleic Acids Res. 1997, 25, 3693-3697.
53. Finnin, M. S.; Donigian, J. R.; Cohen, A.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.; Breslow, R.; Pavletich, N. P. Structures of a Histone Deacetylase Homologue Bound to the TSA and SAHA Inhibitors. Nature 1999, 401, 188-193.
54. Somoza, J. R.; Skene, R. J.; Katz, B. A.; Mol, C.; Ho, J. D.; Jennings, A. J.; Luong, C.; Arvai, A.; Buggy, J. J.; Chi, E.; Tang, J.; Sang, B.-C.; Verner, E.; Wynands, R.; Leahy, E. M.; Dougan, D. R.; Snell, G.; Navre, M.; Knuth, M. W.; Swanson, R. V.; McRee, D. E.; Tari, L. W. Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases. Structure 2004, 12, 1325-1334.
55. Vannini, A.; Volpari, C.; Filocamo, G.; Casavola, E. C.; Brunetti, M.; Renzoni, D.; Chakravarty, P.; Paolini, C.; De Francesco, R.; Gallinari, P.; Steinkuhler, C. Crystal Structure of a Eukaryotic Zinc-Dependent Histone Deacetylase, Human HDAC8, Complexed with a Hydroxamate Inhibitor. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 15064-15069.
56. Laumann, E. O.; Paik, A.; Rosen, R. C. Sexual Dysfunction in the United States: Prevalence and Predictors. J. Am. Med. Assoc. 1999, 281, 537-544.
57. Basson, R.; Berman, J.; Burnett, A.; Derogatis, L.; Ferguson, D.; Fourcroy, J.; Goldstein, I.; Graziottin, A.; Heiman, J.; Laan, E.; Leiblum, S.; Padma-Nathan, H.; Rosen, R.; Segraves, K.; Segraves, R. T.; Shabsigh, R.; Sipski, M.; Wagner, G.; Whipple, B. Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and Classifications. J. Urol. 2000, 163, 888-893.
58. Ignarro, L. J.; Bush, P. A.; Buga, G. M.; Wood, K. S.; Fukuto, J. M.; Rajfer, J. Nitric Oxide and Cyclic GMP Formation upon Electrical Field Stimulation Cause Relaxation of Corpus Cavernosum Smooth Muscle. Biochem. Biophys. Res. Commun. 1990, 170, 843-850.
59. Kim, N.; Azadzoi, K. M.; Goldstein, I.; Saenz de Tejada, I. A Nitric Oxide-Like Factor Mediates Nonadrenergic-Noncholinergic Neurogenic Relaxation of Penile Corpus Cavernosum Smooth Muscle. J. Clin. Invest. 1991, 88, 112-118.
60. Rajfer, J.; Aronson, W. J.; Bush, P. A.; Dorey, F. J.; Ignarro, L. J. Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission. New Engl. J. Med. 1992, 326, 90-94.
61. Lugg, J. A.; Gonzalez-Cadavid, N. F.; Rajfer, J. The Role of Nitric Oxide in Erectile Function. J. Androl. 1995, 16, 2-4.
62. Wei, L. H.; Jacobs, A. T.; Morris, S. M., Jr.; Ignarro, L. J. IL-4 and IL-13 Upregulate Arginase I Expression by cAMP and JAK/STAT6 Pathways in Vascular Smooth Muscle Cells. Am. J. Physiol. 2000, 279, C248-C256.
63. Bivalacqua, T. J.; Hellstrom, W. J. G.; Kadowitz, P. J.; Champion, H. C. Increased Expression of Arginase II in Human Diabetic Corpus Cavernosum: In Diabetic-Associated Erectile Dysfunction. Biochem. Biophys. Res. Commun. 2001, 283, 923-927.
64. Kim, S. W.; Jeong, S.-J.; Munarriz, R.; Kim, N. N.; Goldstein, I.; Traish, A. M. Role of the Nitric Oxide-Cyclic GMP Pathway in Regulation of Vaginal Blood Flow. Int. J. Impot. Res. 2003, 15, 355-361.
65. Moody, J. A.; Vernet, D.; Laidlaw, S.; Rajfer, J.; Gonzalez-Cadavid, N. F. Effects of Long-Term Oral Administration of L-Arginine on the Rat Erectile Response. J. Urol. 1997, 158, 942-947.
66. Zorgniotti, A. W.; Lizza, E. F. Effect of Large Doses of the Nitric Oxide Precursor, L-Arginine, on Erectile Dysfunction. Int. J. Impot. Res. 1994, 6, 33-36.
67. Ito, T. Y.; Trant, A.; Polan, M. L. A Double-Blind Placebo-Controlled Study of ArginMax, a Nutritional Supplement for Enhancement of Female Sexual Function. J. Sex Marital Ther. 2001, 27, 541-549.
68. Chen, J.; Wollman, Y.; Chernichovsky, T.; Iaina, A.; Sofer, M.; Matzkin, H. Effect of Oral Administration of High-Dose Nitric Oxide Donor L-Arginine in Men with Organic Erectile Dysfunction: Results of a Double-Blind, Randomized, Placebo-Controlled Study. Br. J. Urol. Int. 1999, 83, 269-273.
69. Brindley, G. S. Pilot Experiments on the Actions of Drugs Injected into the Human Corpus Cavernosum Penis. Br. J. Pharmacol. 1986, 87, 495-500.
70. Owen, J. A.; Saunders: F.; Harris, C.; Fenemore, J.; Reid, K.; Surridge, D.; Condra, M.; Morales, A. Topical Nitroglycerin: a Potential Treatment for Impotence. J. Urol. 1989, 141, 546-548.
71. Becher, E. F.; Bechara, A.; Casabe, A. Clitoral Hemodynamic Changes after a Topical Application of Alprostadil. J. Sex Marital Ther. 2001, 27, 405-410.